A recent study on the surveillance and laboratory detection capacity for non-polio enteroviruses (NPEV) in the European Union/European Economic Area showed a vast difference between countries. While almost all countries had NPEV surveillance systems in place, the targeted surveillance of EV-D68, surveillance of HFMD, the number of samples typed, the detection and typing methods used, the capacity for serological investigation and availability of clinical data varied. However, country specific numbers are lacking to identify the impact of the variations seen on the numbers of samples tested and typed, as well as to define the circulation of specific NPEV types in Europe and beyond.
Furthermore, the SARS-CoV-2 pandemic and the measures taken had a tremendous effect on the circulation of NPEVs worldwide. Similarly, more severe case presentations might be possible. To generate a collection of country specific surveillance papers showing data on NPEV circulation and typing during the recent years, including the pandemic years 2020-2022. We would also accept case presentations of severe NPEV infections linked to specific NPEV types. The paper will provide insights into the magnitude of data collected over the years per country and the effect of the pandemic and can be placed in the context of surveillance differences across Europe.
The special issue will be a collection of country specific surveillance or case studies related to enterovirus (including parechovirus and rhinovirus) in Europe and beyond
Types of manuscripts that can be submitted are:
- surveillance paper: Surveillance paper should describe the current surveillance system, including methods and population studied) in your country and data (samples tested, types identified) generated in the last years, preferably 3 years before the COVID-19 pandemic and until recent years.
-case studies: Case studies should describe a single case or a cluster of cases with similar symptoms or clinical presentation. The study should preferably include typing data.
-method papers: Methods papers should describe current methods used, adapted, or invented to aid in the surveillance of enteroviruses. These can include serology, culture, or molecular methods and platforms
A recent study on the surveillance and laboratory detection capacity for non-polio enteroviruses (NPEV) in the European Union/European Economic Area showed a vast difference between countries. While almost all countries had NPEV surveillance systems in place, the targeted surveillance of EV-D68, surveillance of HFMD, the number of samples typed, the detection and typing methods used, the capacity for serological investigation and availability of clinical data varied. However, country specific numbers are lacking to identify the impact of the variations seen on the numbers of samples tested and typed, as well as to define the circulation of specific NPEV types in Europe and beyond.
Furthermore, the SARS-CoV-2 pandemic and the measures taken had a tremendous effect on the circulation of NPEVs worldwide. Similarly, more severe case presentations might be possible. To generate a collection of country specific surveillance papers showing data on NPEV circulation and typing during the recent years, including the pandemic years 2020-2022. We would also accept case presentations of severe NPEV infections linked to specific NPEV types. The paper will provide insights into the magnitude of data collected over the years per country and the effect of the pandemic and can be placed in the context of surveillance differences across Europe.
The special issue will be a collection of country specific surveillance or case studies related to enterovirus (including parechovirus and rhinovirus) in Europe and beyond
Types of manuscripts that can be submitted are:
- surveillance paper: Surveillance paper should describe the current surveillance system, including methods and population studied) in your country and data (samples tested, types identified) generated in the last years, preferably 3 years before the COVID-19 pandemic and until recent years.
-case studies: Case studies should describe a single case or a cluster of cases with similar symptoms or clinical presentation. The study should preferably include typing data.
-method papers: Methods papers should describe current methods used, adapted, or invented to aid in the surveillance of enteroviruses. These can include serology, culture, or molecular methods and platforms
